Skip to main content

Security report for mymsd.com.au

Merck Sharp & Dohme (Australia) Pty Limited · Healthcare · Australia

Medium risk. 5 critical or high findings in GDPR outside view, Email security and 1 other check.

Security score

70/100

Risk levelMedium

0–100, higher is better. How it is calculated

myMSD is a professional healthcare information portal operated by Merck Sharp & Dohme (Australia) Pty Limited, targeting Australian healthcare professionals. The site provides access to product information, therapy area resources, clinical trials, and treatment hubs, positioning itself as a trusted resource in the Australian pharmaceutical healthcare market. The website is well-branded, consistent, and clearly intended for a professional audience, with strong compliance to Australian healthcare regulations and privacy standards. Technically, the site is built on WordPress with a modern tech stack including Yoast SEO, Google Tag Manager, New Relic monitoring, and Janrain authentication. It is hosted on a premium platform (WordPress VIP) and uses multiple CDNs and third-party services to optimize performance and user experience. The site is mobile-optimized, accessible, and SEO-friendly, with good navigation and content structure. From a security perspective, the site enforces HTTPS, implements privacy and cookie policies with consent mechanisms, and uses monitoring tools to maintain security posture. While explicit security headers are not fully confirmed, the overall security practices are sound with no visible vulnerabilities or exposed sensitive data. The WHOIS data is privacy-protected but consistent with a legitimate enterprise healthcare entity. Overall, myMSD presents a low-risk, professionally managed digital presence with strong business credibility and compliance. Strategic recommendations include enhancing explicit security headers, publishing a vulnerability disclosure policy, and improving incident response contact visibility to further strengthen trust and security posture.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching mymsd.com.au

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
52
Security headers
85
Email security
50
DNS health
75
Network security
100
GDPR outside view
58
Average
70

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

myMSD operates as an essential healthcare information portal under Merck Sharp & Dohme (Australia) Pty Limited, a subsidiary of Merck & Co., Inc. The business model focuses on providing Australian healthcare professionals with timely access to pharmaceutical product information, clinical trial data, and therapy area resources, particularly in oncology and COVID-19. The site supports user registration and personalized access, indicating a controlled and professional user base. The company leverages partnerships with related MSD domains and external healthcare resources to enrich content. Market positioning is strong within the Australian healthcare sector, supported by consistent branding and regulatory compliance. Growth indicators include active content updates and integration with multiple MSD services. The partnership ecosystem includes clinical trials, access portals, and medical information sites, enhancing the overall value proposition.

Security posture

The security maturity of myMSD is moderate to good. The site enforces HTTPS and integrates privacy and cookie consent mechanisms compliant with GDPR and Australian privacy laws. Use of New Relic for monitoring and Janrain for authentication indicates proactive security management. However, explicit security headers like Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options are not clearly identified and should be verified or implemented. No vulnerabilities or exposed sensitive data were detected in the analysis. Incident response and vulnerability disclosure information are not publicly available, representing an area for improvement. Overall, the site demonstrates a solid security foundation appropriate for a healthcare information portal but would benefit from enhanced transparency and security header implementation.

Recommendations

  1. Implement and verify comprehensive security headers including CSP, X-Frame-Options, and X-Content-Type-Options to mitigate common web attacks.
  2. Publish a public vulnerability disclosure policy and security.txt file to encourage responsible reporting of security issues.
  3. Enhance visibility and accessibility of incident response contact information to improve trust and readiness.
  4. Regularly audit third-party scripts and dependencies for vulnerabilities and update them promptly.
  5. Ensure all user input forms have anti-CSRF tokens and secure validation to prevent injection attacks.

Contact details published on the site

Addresses
Legal name
Merck Sharp & Dohme (Australia) Pty Limited
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Merck Sharp & Dohme (Australia) Pty Limited
Description
Access to product and supported therapy area information – when you need it. This website is intended for use by Australian healthcare professionals only.
Key services
Product information, Therapy area information, Clinical trials information, Oncology treatment resources, User account management
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, jQuery, Google Tag Manager, New Relic monitoring, Janrain authentication, OneTrust cookie consent, Brightcove video player, Cloudfront CDN
Frameworks
WordPress Gutenberg, MConnect theme
Platforms
WordPress VIP hosting
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Login and registration with password management
  • Privacy policy and terms of use clearly linked
  • Cookie consent mechanism implemented
  • Use of security monitoring tools (New Relic)

Analytics and tracking

Services
Google Tag Manager, New Relic
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
New Relic, Janrain
Marketing tools
Janrain, OneTrust
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a professional healthcare portal targeting Australian healthcare professionals.
  2. Content is rich with product, clinical trial, and therapy area information.
  3. Strong privacy and terms of use presence with clear links.
  4. Login and registration system with password management and consent mechanisms.
  5. Use of multiple third-party services for analytics, authentication, and content delivery.
  6. No evidence of adult or questionable content.
  7. No WAF or blocking detected; site fully accessible.
  8. WHOIS data is limited but consistent with privacy protection norms.
Technical notes

Notes

The website is built on a robust WordPress platform using the Gutenberg editor and a custom MConnect theme. It employs modern JavaScript libraries including jQuery and integrates with multiple third-party services such as Google Tag Manager, New Relic, Janrain authentication, and OneTrust for cookie consent. Content delivery is optimized via Cloudfront CDN and Brightcove for video content. The site is mobile responsive and accessible, with good SEO practices implemented via Yoast SEO. Performance is moderate, with room for optimization in script loading and caching. The technical infrastructure is well-maintained with monitoring and analytics in place, supporting a professional and scalable digital presence.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with mymsd.com.au. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review mymsd.com.au.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.